-+ 0.00%
-+ 0.00%
-+ 0.00%

ABPRO HOLDINGS INC: CLINICAL TRIAL ANTICIPATED TO COMMENCE IN FIRST HALF OF 2026 THROUGH ABPRO'S GLOBAL COLLABORATION WITH CELLTRION

Reuters·01/06/2026 12:00:03

Please log in to view news